Publications (199) Publications de José Ignacio Herrero Santos

2024

  1. Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment

    Journal of Physiology and Biochemistry

  2. Ictericias y enfermedades de las vías biliares.

    Medicina interna (Elsevier España), pp. 263-277

  3. New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 5

  4. The Impact of Portal Hypertension Assessment Method on the Outcomes of Hepatocellular Carcinoma Resection: A Meta-Analysis of Matched Cohort and Prospective Studies

    Annals of Surgery, Vol. 280, Núm. 1, pp. 46-55

  5. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis

    Liver International, Vol. 44, Núm. 1, pp. 250-262

2023

  1. Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease

    Journal of Physiology and Biochemistry

  2. Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

    Cancers, Vol. 15, Núm. 3

  3. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

  4. Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases

    BioFactors, Vol. 49, Núm. 4, pp. 912-927

2022

  1. A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers

    Panminerva medica, Vol. 64, Núm. 4, pp. 485-496

  2. Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

    American Journal of Transplantation, Vol. 22, Núm. 6, pp. 1671-1682

  3. De Novo Malignancy after Liver Transplantation: Risk Assessment, Prevention, and Management - Guidelines from the ILTS-SETH Consensus Conference

    Transplantation, Vol. 106, Núm. 1, pp. E30-E45

  4. Evaluation of the quality of multiple-choice questions according to the students’ academic level

    BMC Medical Education, Vol. 22, Núm. 1

  5. Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study

    Nutrients, Vol. 14, Núm. 23

  6. Standard versus extended primary cytomegalovirus prophylaxis in solid organ transplantation

    Medicina Clinica, Vol. 158, Núm. 11, pp. 543-546

  7. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study

    European Journal of Nutrition, Vol. 60, Núm. 4, pp. 1769-1780

  2. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study

    European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3043-3057

  3. Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial

    Liver International, Vol. 41, Núm. 7, pp. 1532-1544

  4. Liver transplant recipients have an increased risk of developing colorectal adenomas: Results from a retrospective study

    Clinical Transplantation, Vol. 35, Núm. 1